An oppression claim failed, the buyout was set, and then the payout hit a sanctions wall
An Ontario court ordered a company to buy out a minority investor, then froze the seven-figure payout pending a federal sanctions ruling.
The endorsement released June 30, 2026 by the Ontario Superior Court of Justice's Commercial List, resolved a fight between a Maltese investment company and the controlling shareholders of an Ontario cancer-diagnostics firm. The investor had put US$250,000 into the firm in 2018 for 125,000 shares, a stake of about 14.5%.
The case turned on an oppression application under section 248 of Ontario's Business Corporations Act. The investor argued the firm's directors ran a series of related-party deals through an affiliated buyer while concealing their own ownership of it. Three agreements were challenged: an option letting the affiliated company acquire 51% of the firm at a US$10 million valuation, a licensing deal, and the transfer of the firm's 89% interest in a Russian subsidiary for no payment.
Justice W.D. Black was not persuaded. He found the investor knew, or should have known, about the overlapping ownership from the outset, having been shown a corporate chart when it invested and having helped draft the very agreements it later attacked. The oppression claim was not made out, he ruled, and there was no basis for personal liability against the individual respondents. He found nothing approaching deceit, dishonesty, or bad faith.
What makes the ruling useful for advisors and firms with private-company clients is what came next. Both sides agreed the company should buy out the investor's shares. The buyout then collided with Canada's Russia-sanctions regime.
The respondents argued the investor was effectively controlled by a sanctioned Russian insurer, whose founders sit on Canada's sanctions list, so any court-ordered payment could breach the rules under the Special Economic Measures Act. The investor said it was not sanctioned, its owners were not sanctioned, and the concern was raised only to sideline it.
The judge accepted that the timing looked tactical. Even so, he said the motives did not matter. Pointing to a series of regulatory "red flags," including the owners' senior roles at the sanctioned insurer, he found a real issue over whether the investor is caught by the sanctions rules. He declined to clear it and left that question to Global Affairs Canada, which is already weighing submissions from both sides.
The practical result was that the court set a price but withheld the cash. Using the midpoint of competing expert valuations, the judge pegged the firm at US$11,944,500 and the investor's stake at US$1,731,952.50 before any discount. Because no oppression was found, he directed a 10% minority discount. No money can move until Global Affairs Canada rules.
For compliance officers and fund managers, the takeaway is direct. Sanctions exposure can freeze even an agreed transaction, and a court may refuse to release funds until a federal regulator signs off. Costs were left for a later ruling.
